Benzinga | Nov 3, 2020 07:31AM EST

GW Pharmaceuticals Q3 EPS $(0.03) Beats $(0.83) Estimate, Sales $137.10M Beat $127.37M Estimate

GW Pharmaceuticals (NASDAQ:GWPH) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.83) by 96.39 percent. This is a 50 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $137.10 million which beat the analyst consensus estimate of $127.37 million by 7.64 percent. This is a 90.32 percent increase over sales of $72.04 million the same period last year.